Global Mitomycin C Market Research Report 2021

Code: QYRE-Auto-19D4303

Report

February 2021

95 Pages

QYResearch

Region: Global, North America, Germany, Europe, Canada, France, Saudi Arabia, Turkey, Argentina, Middle East & Africa, Brazil, Japan, Philippines, Malaysia, Thailand, Indonesia, Vietnam, South Korea, India, Australia, Taiwan, Italy,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Kyowa Kirin

Intas Pharmaceuticals

TEVA

Bristol–Myers Squibb

Aspen

Contura

Alkem Laboratories

Varifarma

APOGEPHA

Company

Russia

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

2 Mg

10 Mg

40 Mg

Other

Segment by Application

Cancer Treatment

Ophthalmic Use

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Kyowa-kirin

Intas Pharmaceuticals

Teva

Bristol-Myers Squibb

Aspen

Contura

Alkem Laboratories

Varifarma

APOGEPHA

FEATURED COMPANIES

Kyowa Kirin

Intas Pharmaceuticals

TEVA

Bristol–Myers Squibb

Aspen

Contura

Alkem Laboratories

Varifarma

APOGEPHA

Company

Russia

1 Mitomycin C Market Overview

1.1 Product Overview and Scope of Mitomycin C

1.2 Mitomycin C Segment by Type

1.2.1 Global Mitomycin C Sales Growth Rate Comparison by Type (2021-2027)

1.2.2 2 Mg

1.2.3 10 Mg

1.2.4 40 Mg

1.2.5 Other

1.3 Mitomycin C Segment by Application

1.3.1 Mitomycin C Sales Comparison by Application: (2021-2027)

1.3.2 Cancer Treatment

1.3.3 Ophthalmic Use

1.3.4 Others

1.4 Global Mitomycin C Market Size Estimates and Forecasts

1.4.1 Global Mitomycin C Revenue 2016-2027

1.4.2 Global Mitomycin C Sales 2016-2027

1.4.3 Mitomycin C Market Size by Region: 2016 Versus 2021 Versus 2027

2 Mitomycin C Market Competition by Manufacturers

2.1 Global Mitomycin C Sales Market Share by Manufacturers (2016-2021)

2.2 Global Mitomycin C Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Mitomycin C Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Mitomycin C Manufacturing Sites, Area Served, Product Type

2.5 Mitomycin C Market Competitive Situation and Trends

2.5.1 Mitomycin C Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Mitomycin C Players Market Share by Revenue

2.5.3 Global Mitomycin C Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mitomycin C Retrospective Market Scenario by Region

3.1 Global Mitomycin C Retrospective Market Scenario in Revenue by Region: 2016-2021

3.2 Global Mitomycin C Retrospective Market Scenario in Sales by Region: 2016-2021

3.3 North America Mitomycin C Market Facts & Figures by Country

3.3.1 North America Mitomycin C Sales by Country

3.3.2 North America Mitomycin C Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Mitomycin C Market Facts & Figures by Country

3.4.1 Europe Mitomycin C Sales by Country

3.4.2 Europe Mitomycin C Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Mitomycin C Market Facts & Figures by Region

3.5.1 Asia Pacific Mitomycin C Sales by Region

3.5.2 Asia Pacific Mitomycin C Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Mitomycin C Market Facts & Figures by Country

3.6.1 Latin America Mitomycin C Sales by Country

3.6.2 Latin America Mitomycin C Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Mitomycin C Market Facts & Figures by Country

3.7.1 Middle East and Africa Mitomycin C Sales by Country

3.7.2 Middle East and Africa Mitomycin C Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4 Global Mitomycin C Historic Market Analysis by Type

4.1 Global Mitomycin C Sales Market Share by Type (2016-2021)

4.2 Global Mitomycin C Revenue Market Share by Type (2016-2021)

4.3 Global Mitomycin C Price by Type (2016-2021)

5 Global Mitomycin C Historic Market Analysis by Application

5.1 Global Mitomycin C Sales Market Share by Application (2016-2021)

5.2 Global Mitomycin C Revenue Market Share by Application (2016-2021)

5.3 Global Mitomycin C Price by Application (2016-2021)

6 Key Companies Profiled

6.1 Kyowa-kirin

6.1.1 Kyowa-kirin Corporation Information

6.1.2 Kyowa-kirin Description and Business Overview

6.1.3 Kyowa-kirin Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.1.4 Kyowa-kirin Product Portfolio

6.1.5 Kyowa-kirin Recent Developments/Updates

6.2 Intas Pharmaceuticals

6.2.1 Intas Pharmaceuticals Corporation Information

6.2.2 Intas Pharmaceuticals Description and Business Overview

6.2.3 Intas Pharmaceuticals Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.2.4 Intas Pharmaceuticals Product Portfolio

6.2.5 Intas Pharmaceuticals Recent Developments/Updates

6.3 Teva

6.3.1 Teva Corporation Information

6.3.2 Teva Description and Business Overview

6.3.3 Teva Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.3.4 Teva Product Portfolio

6.3.5 Teva Recent Developments/Updates

6.4 Bristol-Myers Squibb

6.4.1 Bristol-Myers Squibb Corporation Information

6.4.2 Bristol-Myers Squibb Description and Business Overview

6.4.3 Bristol-Myers Squibb Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Bristol-Myers Squibb Product Portfolio

6.4.5 Bristol-Myers Squibb Recent Developments/Updates

6.5 Aspen

6.5.1 Aspen Corporation Information

6.5.2 Aspen Description and Business Overview

6.5.3 Aspen Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.5.4 Aspen Product Portfolio

6.5.5 Aspen Recent Developments/Updates

6.6 Contura

6.6.1 Contura Corporation Information

6.6.2 Contura Description and Business Overview

6.6.3 Contura Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.6.4 Contura Product Portfolio

6.6.5 Contura Recent Developments/Updates

6.7 Alkem Laboratories

6.6.1 Alkem Laboratories Corporation Information

6.6.2 Alkem Laboratories Description and Business Overview

6.6.3 Alkem Laboratories Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Alkem Laboratories Product Portfolio

6.7.5 Alkem Laboratories Recent Developments/Updates

6.8 Varifarma

6.8.1 Varifarma Corporation Information

6.8.2 Varifarma Description and Business Overview

6.8.3 Varifarma Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.8.4 Varifarma Product Portfolio

6.8.5 Varifarma Recent Developments/Updates

6.9 APOGEPHA

6.9.1 APOGEPHA Corporation Information

6.9.2 APOGEPHA Description and Business Overview

6.9.3 APOGEPHA Mitomycin C Sales, Revenue and Gross Margin (2016-2021)

6.9.4 APOGEPHA Product Portfolio

6.9.5 APOGEPHA Recent Developments/Updates

7 Mitomycin C Manufacturing Cost Analysis

7.1 Mitomycin C Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Mitomycin C

7.4 Mitomycin C Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Mitomycin C Distributors List

8.3 Mitomycin C Customers

9 Mitomycin C Market Dynamics

9.1 Mitomycin C Industry Trends

9.2 Mitomycin C Growth Drivers

9.3 Mitomycin C Market Challenges

9.4 Mitomycin C Market Restraints

10 Global Market Forecast

10.1 Mitomycin C Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Mitomycin C by Type (2022-2027)

10.1.2 Global Forecasted Revenue of Mitomycin C by Type (2022-2027)

10.2 Mitomycin C Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Mitomycin C by Application (2022-2027)

10.2.2 Global Forecasted Revenue of Mitomycin C by Application (2022-2027)

10.3 Mitomycin C Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Mitomycin C by Region (2022-2027)

10.3.2 Global Forecasted Revenue of Mitomycin C by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

FEATURED COMPANIES

Kyowa Kirin

Intas Pharmaceuticals

TEVA

Bristol–Myers Squibb

Aspen

Contura

Alkem Laboratories

Varifarma

APOGEPHA

Company

Russia

List of Tables

Table 1. Global Mitomycin C Sales (K Units) Growth Rate Comparison by Type (2021-2027)

Table 2. Global Mitomycin C Sales (K Units) Comparison by Application (2021-2027)

Table 3. Global Mitomycin C Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)

Table 4. Key Manufacturers Mitomycin C Covered in This Study

Table 5. Global Mitomycin C Sales (K Units) of Key Manufacturers (2016-2021)

Table 6. Global Mitomycin C Sales Share by Manufacturers (2016-2021)

Table 7. Global Mitomycin C Revenue (US$ Million) by Manufacturers (2016-2021)

Table 8. Global Mitomycin C Revenue Share by Manufacturers (2016-2021)

Table 9. Global Market Mitomycin C Average Price (USD/Unit) of Key Manufacturers (2016-2021)

Table 10. Manufacturers Mitomycin C Manufacturing Sites and Area Served

Table 11. Manufacturers Mitomycin C Product Type

Table 12. Global Mitomycin C Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Mitomycin C by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitomycin C as of 2020)

Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Global Mitomycin C Sales by Region (2016-2021) & (K Units)

Table 16. Global Mitomycin C Sales Market Share by Region (2016-2021)

Table 17. Global Mitomycin C Revenue by Region (2016-2021) & (US$ Million)

Table 18. North America Mitomycin C Sales by Country (2016-2021) & (K Units)

Table 19. North America Mitomycin C Sales Market Share by Country (2016-2021)

Table 20. North America Mitomycin C Revenue by Country (2016-2021) & (US$ Million)

Table 21. North America Mitomycin C Revenue Market Share by Country (2016-2021)

Table 22. Europe Mitomycin C Sales by Country (2016-2021) & (K Units)

Table 23. Europe Mitomycin C Sales Market Share by Country (2016-2021)

Table 24. Europe Mitomycin C Revenue by Country (2016-2021) & (US$ Million)

Table 25. Europe Mitomycin C Revenue Market Share by Country (2016-2021)

Table 26. Asia Pacific Mitomycin C Sales by Region (2016-2021) & (K Units)

Table 27. Asia Pacific Mitomycin C Sales Market Share by Region (2016-2021)

Table 28. Asia Pacific Mitomycin C Revenue by Region (2016-2021) & (US$ Million)

Table 29. Asia Pacific Mitomycin C Revenue Market Share by Region (2016-2021)

Table 30. Latin America Mitomycin C Sales by Country (2016-2021) & (K Units)

Table 31. Latin America Mitomycin C Sales Market Share by Country (2016-2021)

Table 32. Latin America Mitomycin C Revenue by Country (2016-2021) & (US$ Million)

Table 33. Latin America Mitomycin C Revenue Market Share by Country (2016-2021)

Table 34. Middle East and Africa Mitomycin C Sales by Country (2016-2021) & (K Units)

Table 35. Middle East and Africa Mitomycin C Sales Market Share by Country (2016-2021)

Table 36. Middle East and Africa Mitomycin C Revenue by Country (2016-2021) & (US$ Million)

Table 37. Middle East and Africa Mitomycin C Revenue Market Share by Country (2016-2021)

Table 38. Global Mitomycin C Sales (K Units) by Type (2016-2021)

Table 39. Global Mitomycin C Sales Market Share by Type (2016-2021)

Table 40. Global Mitomycin C Revenue (Million US$) by Type (2016-2021)

Table 41. Global Mitomycin C Revenue Share by Type (2016-2021)

Table 42. Global Mitomycin C Price (USD/Unit) by Type (2016-2021)

Table 43. Global Mitomycin C Sales (K Units) by Application (2016-2021)

Table 44. Global Mitomycin C Sales Market Share by Application (2016-2021)

Table 45. Global Mitomycin C Revenue (Million US$) by Application (2016-2021)

Table 46. Global Mitomycin C Revenue Share by Application (2016-2021)

Table 47. Global Mitomycin C Price (USD/Unit) by Application (2016-2021)

Table 48. Kyowa-kirin Corporation Information

Table 49. Kyowa-kirin Description and Business Overview

Table 50. Kyowa-kirin Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 51. Kyowa-kirin Mitomycin C Product

Table 52. Kyowa-kirin Recent Developments/Updates

Table 53. Intas Pharmaceuticals Corporation Information

Table 54. Intas Pharmaceuticals Description and Business Overview

Table 55. Intas Pharmaceuticals Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 56. Intas Pharmaceuticals Mitomycin C Product

Table 57. Intas Pharmaceuticals Recent Developments/Updates

Table 58. Teva Corporation Information

Table 59. Teva Description and Business Overview

Table 60. Teva Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 61. Teva Mitomycin C Product

Table 62. Teva Recent Developments/Updates

Table 63. Bristol-Myers Squibb Corporation Information

Table 64. Bristol-Myers Squibb Description and Business Overview

Table 65. Bristol-Myers Squibb Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 66. Bristol-Myers Squibb Mitomycin C Product

Table 67. Bristol-Myers Squibb Recent Developments/Updates

Table 68. Aspen Corporation Information

Table 69. Aspen Description and Business Overview

Table 70. Aspen Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 71. Aspen Mitomycin C Product

Table 72. Aspen Recent Developments/Updates

Table 73. Contura Corporation Information

Table 74. Contura Description and Business Overview

Table 75. Contura Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 76. Contura Mitomycin C Product

Table 77. Contura Recent Developments/Updates

Table 78. Alkem Laboratories Corporation Information

Table 79. Alkem Laboratories Description and Business Overview

Table 80. Alkem Laboratories Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 81. Alkem Laboratories Mitomycin C Product

Table 82. Alkem Laboratories Recent Developments/Updates

Table 83. Varifarma Corporation Information

Table 84. Varifarma Description and Business Overview

Table 85. Varifarma Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 86. Varifarma Mitomycin C Product

Table 87. Varifarma Recent Developments/Updates

Table 88. APOGEPHA Corporation Information

Table 89. APOGEPHA Description and Business Overview

Table 90. APOGEPHA Mitomycin C Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)

Table 91. APOGEPHA Mitomycin C Product

Table 92. APOGEPHA Recent Developments/Updates

Table 93. Production Base and Market Concentration Rate of Raw Material

Table 94. Key Suppliers of Raw Materials

Table 95. Mitomycin C Distributors List

Table 96. Mitomycin C Customers List

Table 97. Mitomycin C Market Trends

Table 98. Mitomycin C Growth Drivers

Table 99. Mitomycin C Market Restraints

Table 100. Global Mitomycin C Sales Forecast by Type (2022-2027) & (K Units)

Table 101. Global Mitomycin C Sales Market Share Forecast by Type (2022-2027)

Table 102. Global Mitomycin C Revenue Forecast by Type (2022-2027) & (US$ Million)

Table 103. Global Mitomycin C Revenue Market Share Forecast by Type (2022-2027)

Table 104. Global Mitomycin C Sales Forecast by Application (2022-2027) & (K Units)

Table 105. Global Mitomycin C Sales Market Share Forecast by Application (2022-2027)

Table 106. Global Mitomycin C Revenue Forecast by Application (2022-2027) & (US$ Million)

Table 107. Global Mitomycin C Revenue Market Share Forecast by Application (2022-2027)

Table 108. Global Mitomycin C Sales Forecast by Region (2022-2027) & (K Units)

Table 109. Global Mitomycin C Sales Market Share Forecast by Region (2022-2027)

Table 110. Global Mitomycin C Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 111. Global Mitomycin C Revenue Market Share Forecast by Region (2022-2027)

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Mitomycin C

Figure 2. Global Mitomycin C Market Share by Type in 2020 & 2027

Figure 3. 2 Mg Product Picture

Figure 4. 10 Mg Product Picture

Figure 5. 40 Mg Product Picture

Figure 6. Other Product Picture

Figure 7. Global Mitomycin C Market Share by Application in 2020 & 2027

Figure 8. Cancer Treatment

Figure 9. Ophthalmic Use

Figure 10. Others

Figure 11. Global Mitomycin C Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 12. Global Mitomycin C Market Size 2016-2027 (US$ Million)

Figure 13. Global Mitomycin C Sales 2016-2027 (K Units)

Figure 14. Global Mitomycin C Market Size Market Share by Region: 2016 VS 20210 VS 2027

Figure 15. Mitomycin C Sales Share by Manufacturers in 2020

Figure 16. Global Mitomycin C Revenue Share by Manufacturers in 2020

Figure 17. The Global 5 and 10 Largest Mitomycin C Players: Market Share by Revenue in 2020

Figure 18. Mitomycin C Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021

Figure 19. Global Mitomycin C Sales Market Share by Region (2016-2021)

Figure 20. Global Mitomycin C Sales Market Share by Region in 2020

Figure 21. Global Mitomycin C Revenue Market Share by Region (2016-2021)

Figure 22. Global Mitomycin C Revenue Market Share by Region in 2020

Figure 23. U.S. Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 24. Canada Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 25. Germany Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 26. France Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 27. U.K. Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 28. Italy Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 29. Russia Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 30. China Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 31. Japan Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 32. South Korea Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 33. India Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 34. Australia Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 35. Taiwan Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 36. Indonesia Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 37. Thailand Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 38. Malaysia Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 39. Philippines Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 40. Vietnam Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 41. Mexico Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 42. Brazil Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 43. Argentina Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 44. Turkey Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 45. Saudi Arabia Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 46. U.A.E Mitomycin C Revenue Growth Rate (2016-2021) (US$ Million)

Figure 47. Sales Market Share of Mitomycin C by Type (2016-2021)

Figure 48. Sales Market Share of Mitomycin C by Application (2016-2021)

Figure 49. Sales Market Share of Mitomycin C by Application in 2020

Figure 50. Revenue Share of Mitomycin C by Application (2016-2021)

Figure 51. Revenue Share of Mitomycin C by Application in 2020

Figure 52. Manufacturing Cost Structure of Mitomycin C

Figure 53. Manufacturing Process Analysis of Mitomycin C

Figure 54. Mitomycin C Industrial Chain Analysis

Figure 55. Channels of Distribution

Figure 56. Distributors Profiles

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed